-
Phase 1/Phase 2
-
-
18+Altersgruppe
-
6Standorte
-
Recruiting
Recruiting
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
This is a study of BMS-986490 as a monotherapy and in combination with bevacizumab in participants with select advanced solid tumors known to express CEACAM5.
Experimental: Part 1A
Experimental: Part 1B
Experimental: Part 2A - Colorectal Cancer (CRC)
Experimental: Part 2A - Non-Small Cell Lung Cancer/Gastric Cancer (NSCLC/GC)
Experimental: Part 2B